Blog

[:content [\T \h \e \space \a \n \n \o \u \n \c \e \m \e \n \t \space \b \y \space \t \h \e \space \A \b \b \o \t \t \space \G \o \v \e \r \n \m \e \n \t \space \t \o \d \a \y \space \t \h \a \t \space \i \t \space \h \a \s \space \c \o \n \f \i \r \m \e \d \space \a \space \n \e \w \space \t \h \r \e \s \h \o \l \d \space \f \o \r \space \C \a \b \i \n \e \t \space \a \p \p \r \o \v \a \l \space \o \f \space \n \e \w \space \m \e \d \i \c \i \n \e \s " ..."]]

The Australian Commission on Safety and Quality in Health Care (ACSQHC, the Commission) is developing a national standardised medication chart for PBS ...

Australian biopharmaceutical company Specialised Therapeutics Australia (STA) is pleased to announce that Abraxane (nanoparticle albumin-bound paclitaxel) in combination with gemcitabine in ...

Medicines Australia welcomes the announcement of a review of the PBAC Guidelines. ...

[:content [\A \space \p \h \a \r \m \a \c \e \u \t \i \c \a \l \space \g \i \a \n \t \space \t \h \a \t \space \i \s \space \t \o \space \r \e \c \e \i \v \e \space \m \o \n \e \y \space \f \r \o \m \space \t \h \e \space \V \i \c \t \o \r \i \a \n \space \g \o \v \e \r \n \m \e \n \t \space \i \n \space \a \space \b \i \d \space \t \o \space \b \o \o \s \t \space \h \i \g \h \- \t \e \c \h \space \j \o \b \s \space \i \n " ..."]]

Biogen Idec is pleased to announce that from 1st March 2015 Plegridy (peginterferon beta-1a) will be listed on the Pharmaceutical Benefits ...

The expert body that recommends drugs for subsidy has hit back at a pharmaceutical industry push to fast-track listings for ...

[:content [\4 \space \D \e \c \e \m \b \e \r \space \2 \0 \1 \3 \space \- \  \C \y \s \t \i \c \space \F \i \b \r \o \s \i \s \space \A \u \s \t \r \a \l \i \a \space \( \C \F \A \) \space \c \a \n \space \c \o \n \f \i \r \m \space \t \h \a \t \space \K \a \l \y \d \e \c \o \space \w \a \s \space \d \i \s \c \u \s \s \e \d \space \a \t \space \t \h \e \space \N \o \v \e \m \b \e \r \space \m \e \e \t \i \n \g \space \o \f \t \h \e \space \P \h \a \r \m \a \c \e \u \t \i \c \a \l \space \B \e \n \e \f \i \t \s " ..."]]

Biogen Idec is pleased to announce that Plegridy (peginterferon beta-1a) has been approved by the Therapeutic Goods Administration (TGA) for treatment of adults ...

The Abbott Government is continuing to work closely with the entire pharmaceutical supply chain, including consumers, to deliver an overarching ...

Actelion Ltd today announced the approval of Opsumit (macitentan) for the treatment of pulmonary arterial hypertension (PAH) by the Therapeutic ...

Australian biopharmaceutical company Specialised Therapeutics Australia (STA) is pleased to announce Abraxane (nanoparticle albumin-bound paclitaxel) in combination with gemcitabine, will be ...

[:content [\7 \space \M \a \r \c \h \space \2 \0 \1 \4 \space \- \  \F \r \o \m \space \1 \space \A \p \r \i \l \space \2 \0 \1 \4 \, \space \t \h \e \space \G \o \v \e \r \n \m \e \n \t \space \w \i \l \l \space \i \m \p \l \e \m \e \n \t \space \a \space \n \e \w \space \s \t \r \e \a \m \l \i \n \e \d \space \p \r \o \c \e \s \s \space \t \o \space \r \e \d \u \c \e \space \t \h \e \space \t \i \m \e \space \t \a \k \e \n " ..."]]

[:content [\2 \8 \space \A \p \r \i \l \space \2 \0 \1 \4 \space \- \  \V \e \r \t \e \x \â \€ \™ \space \c \y \s \t \i \c \space \f \i \b \r \o \s \i \s \space \( \C \F \) \space \d \r \u \g \space \t \r \e \a \t \m \e \n \t \space \K \a \l \y \d \e \c \o \space \( \i \v \a \c \a \f \t \o \r \) \space \s \h \o \u \l \d \space \b \e \space \l \i \s \t \e \d \space \o \n \space \t \h \e \space \P \B \S \, \space \b \u \t \space \i \f \space \p \a \t \i \e \n \t \s " ..."]]